NEURAXIS, INC. Amortization of Intangible Assets
NEURAXIS, INC. (NRXS) reported Amortization of Intangible Assets of $21.81 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-19
- NEURAXIS, INC. amortization of intangible assets for the quarter ending 2023-12-31 was $2.62K, a 44.91% decline year-over-year.
- NEURAXIS, INC. amortization of intangible assets for the quarter ending 2023-09-30 was $2.62K, a 440.41% increase year-over-year.
- NEURAXIS, INC. amortization of intangible assets for the quarter ending 2023-06-30 was $2.62K, a 440.41% increase year-over-year.
- NEURAXIS, INC. amortization of intangible assets for the quarter ending 2022-12-31 was $4.76K.
- NEURAXIS, INC. amortization of intangible assets for fiscal 2025 was $21.81K, a 89.90% increase from fiscal 2024.
- NEURAXIS, INC. amortization of intangible assets for fiscal 2024 was $11.48K, a 9.54% increase from fiscal 2023.
- NEURAXIS, INC. amortization of intangible assets for fiscal 2023 was $10.48K, a 68.76% increase from fiscal 2022.
- NEURAXIS, INC. amortization of intangible assets for fiscal 2022 was $6.21K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $21.81K 10-K · filed 2026-03-19 | |||
| 2024-12-31 | $11.48K 10-K · filed 2026-03-19 | |||
| 2023-12-31 | $2.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $5.24K derived: sum of 2 quarters · filed 2025-03-20 | $7.86K derived: sum of 3 quarters · filed 2025-03-20 | $10.48K 10-K · filed 2025-03-20 |
| 2023-09-30 | $2.62K 10-Q · filed 2023-11-20 | $5.24K derived: sum of 2 quarters · filed 2023-11-20 | $7.86K 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $2.62K 10-Q · filed 2023-09-22 | $5.24K 10-Q · filed 2023-09-22 | ||
| 2022-12-31 | $4.76K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $5.24K derived: sum of 2 quarters · filed 2024-04-16 | $5.73K derived: sum of 3 quarters · filed 2024-04-16 | $6.21K 10-K · filed 2024-04-16 |
| 2022-09-30 | $485.00 10-Q · filed 2023-11-20 | $970.00 derived: sum of 2 quarters · filed 2023-11-20 | $1.46K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $485.00 10-Q · filed 2023-09-22 | $970.00 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |